Brief Description: Described herein is a method of treating or ameliorating cancer in a subject in need thereof. The cancer includes a cytoplasmic RTK fusion protein aggregate. The method includes administering to the subject an inhibitor for the RTK fusion protein, and an inhibitor for matrix metalloprotease. Also described herein is a composition or a kit for treating or ameliorating cancer according to the method
Image:
Caption:
Reference Media Title: Intellectual Property Title: Intellectual Property:
Intellectual Property: US2023-0101403A1
Docket Number: Docket#: 22-9803